BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 25, 2020
View Archived Issues
The bow ties that bind
Read More
FOXO1 regulates HIV latency
Read More
Novel candidate genes identified for Hirschsprung's disease
Read More
Positive data presented from SPIRIT 1 study of relugolix combination therapy in endometriosis
Read More
The role of c-Rel in the generation of suppressive myeloid cells that promote cancer
Read More
GOLT1A-KISS1 gene fusion has a metastatic role in adenoid cystic carcinoma and other cancer types
Read More
BTK inhibitors may decrease the pathological inflammatory response in severe COVID-19 patients
Read More
Seelos presents final phase I safety data for SLS-002 and additional clinical development plans
Read More
Enrollment of first patient in phase II study of pamrevlumab in acute COVID-19
Read More
Palatin to develop PL-8177 for the treatment of COVID-19 and associated lung complications
Read More
Amgen supports further development of AMG-634
Read More
SIK3 inhibitor OMX-0370 shows promising antitumor activity
Read More
Rohto Pharmaceutical to evaluate ADR-001 in patients with COVID-19 severe pneumonia
Read More
USP53 identified as a causal gene for intrahepatic cholestasis
Read More
Loss-of-function variants in TBC1D2B linked to neurodevelopmental disorder with seizures
Read More
AGILeBiotics patents new antibacterials
Read More
Merck KGaA divulges new tankyrase inhibitors
Read More
Hangzhou Innogate Pharma presents new CDK and HDAC dual inhibitors
Read More
Esteve Pharmaceuticals discloses new analgesics
Read More
Chinese researchers divulge S1P receptor 1 agonists
Read More
European phase III study of MOB-015 for onychomycosis meets primary endpoint
Read More
Poxel reports PK/PD study data on PXL-770 in likely NASH patients with insulin resistance
Read More
Berlin Cures plans to evaluate BC-007 for COVID-19
Read More
Phase II data support progression of arimoclomol into pivotal-stage development in Gaucher disease
Read More
AACR Virtual Meeting II: Combination therapies: Searching for synergy
Read More
Phase III study of Ultomiris SC in PNH meets primary endpoint
Read More
MediGene receives Dutch clearance to begin phase I trial of MDG-1021 in hematological cancers
Read More
FDA approves Keytruda for recurrent or metastatic cutaneous squamous cell carcinoma
Read More
FDA clears IND for phase II study of NRD135S-E1 in painful diabetic peripheral neuropathy
Read More
Biohaven to advance troriluzole for OCD based on phase II/III proof-of-concept results
Read More